Skip to main content

Rhino Health

Category: AI in Healthcare

Rhino Health provides a federated computing platform that enables AI developers and medical researchers to collaboratively train AI models on distributed, sensitive healthcare data without compromising privacy. Rhino Health was founded in 2021. The company is led by Ittai Dayan, MD, MPH. Based in Boston, Massachusetts, USA (HQ); with offices in Tel Aviv, Israel. Team size: N/A. Total funding raised: $16M. Latest round: Series A ($15.0M, 2025-05) - Rhino Health. Key investors include Multiple investors (detailed investor information not publicly disclosed).

Founded
2021
Headquarters
Boston, Massachusetts, USA (HQ); with offices in Tel Aviv, Israel
Team size
N/A
Total funding
$16M

Value proposition

Enables secure, privacy-preserving collaboration on sensitive health data to accelerate the development and deployment of AI solutions in healthcare, reducing drug discovery costs and improving clinical trial outcomes.

Products and solutions

Rhino Health Platform (supporting federated learning, edge-compute, generative AI, LLMs, and biostatistics)

Unique value

Focus on federated computing for privacy-preserving AI development in healthcare, allowing data to remain at its source while models are trained centrally to address data sovereignty and privacy concerns.

Target customer

Healthcare organizations (hospitals, research institutions), biopharma companies, and AI developers in the life sciences industry.

Industries served

Healthcare, Life Sciences, Biopharma

Technology advantage

End-to-end platform that leverages federated learning and edge computing, facilitating access to diverse datasets without direct data sharing to enable more robust and generalizable AI models.

How they differentiate

Specialized focus on healthcare and life sciences with an end-to-end platform supporting advanced AI applications including generative AI and LLMs, while ensuring data privacy and regulatory compliance.

Main competitors

Owkin, H2O.ai, Other federated learning and data privacy solution providers

Key partnerships

NVIDIA (Inception Program)

Notable customers

Collaboration with 20 global institutions for training and testing AI models, Published study investigating the performance of an AI algorithm for detecting brain aneurysms across four different sites

Major milestones

Closing multiple funding rounds including a recent Seed round Establishing a large federated network of healthcare organizations Successful application of the platform in federated generative AI, LLMs, and biostatistics Recognition of CEO Ittai Dayan as an emerging leader in healthcare

Growth metrics

Built the world’s largest federated network of healthcare organizations (over 40 and growing).

Market positioning

A rapidly growing company enabling secure AI collaboration without data sharing, positioning itself as a leader in federated computing for the healthcare industry.

Geographic focus

Global, with a significant presence in the US and Israel and a growing network of healthcare organizations worldwide.

Patents and IP

Not specified

About Ittai Dayan, MD, MPH

Ittai Dayan, MD, MPH, is a physician, public health professional, and entrepreneur. He co-founded Rhino Health in 2021 and serves as its CEO. His background includes working as a consultant at Boston Consulting Group (BCG) and as a physician at Sheba Medical Center. He was recognized in Forbes 30 Under 30.

Official website: